Proposed Subscription to Raise $25m and Notice of General Meeting
December 17, 2018 02:05 ET
|
Summit Therapeutics plc
THIS ANNOUNCEMENT (INCLUDING THE APPENDICES) AND THE INFORMATION CONTAINED HEREIN IS RESTRICTED AND IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, OR...
Summit Reports Financial Results for the Second Quarter Ended 31 July 2018 and Operational Progress
September 20, 2018 07:00 ET
|
Summit Therapeutics plc
Summit Therapeutics plc(‘Summit’, the ‘Company’ or the ‘Group’) Summit Therapeutics Reports Financial Results for the Second Quarter and Half Year Ended 31 July 2018 and Operational Progress ...
Total voting rights
September 03, 2018 06:00 ET
|
Summit Therapeutics plc
Summit Therapeutics plc(‘the Company’) Total voting rights Oxford, UK, and Cambridge, MA, US 3 September 2018 – Summit Therapeutics plc (AIM:SUMM, NASDAQ:SMMT), announces that in accordance with the...
Summit Unveils Second Novel Target for Gonorrhoea at ASM Microbe 2018
June 11, 2018 07:00 ET
|
Summit Therapeutics plc
Highlights the Power of the Discuva Platform to Identify Novel Antibiotic Targets OXFORD, United Kingdom and CAMBRIDGE, Mass., June 11, 2018 (GLOBE NEWSWIRE) -- Summit Therapeutics plc...